The global Scaffold Technology market size is expected to be worth around US$ 1.92 billion by 2027, according to a new report by Vision Research Reports.
The global Scaffold Technology market size was valued at US$ 968 million in 2019 and is anticipated to grow at a CAGR of 9.04% during forecast period 2020 to 2027.
The market is driven by a high demand for body reconstruction procedures and a rise in organ transplantations globally. The biomimetic tissue constructs designed by scaffold technology generate 3D organotypic structure, which improves the transplantation processes, consequently boosting the organic revenue growth of the market.
The commercial success of 3D cell culture over the 2D culture system for histological analysis and drug screening purposes has provided lucrative growth avenues for scaffold technology used during 3D cell culturing.
The broadening horizon of scaffold technology in drug development procedures fuels the market progression. The continual attrition rate in drug development caused due to the inability of monolayer cell culture paves a path for the adoption of scaffold-based cultures that efficiently mimic the disease-causing microenvironment.
The use of biomatrix with incorporated nanoparticles for drug delivery and tissue repair is expected to have a high success rate in the near future. The combination of biomaterials and an emerging concept useful in cell delivery and tissue construction, which positively impacts the revenue generation in this application. In addition, the presence of supportive organizations, such as the International Society for Stem Cell Research, boosts the demand for 3D scaffolds in this application.
Report Highlights
The hydrogels segment accounted for the largest revenue share of 42% in 2019. This is attributed to the properties related to the application of hydrogels, such as the ease of loading drugs and cells for controlled drug delivery. In recent years, hydrogels have gained demand as a leading candidate in 3D cell cultivation and tissue engineering. Ongoing technological advancements in the microfabrication of hydrogels are expected to boost revenue generation in this segment.
The nanofiber-based scaffolds segment is anticipated to witness the fastest growth during the forecast period. The nanoscale fibrous structures with interconnecting pores designed by the electrospinning technique facilitate the formation of artificial functional tissues during tissue engineering. These artificial tissues resemble the natural extracellular matrix in tissues, thus enhancing tissue engineering by providing a similar extracellular matrix of living tissues.
The stem cell therapy, regenerative medicine, and tissue engineering application segment dominated the market with a revenue share of 66% in 2019 and is expected to witness the fastest growth from 2020 to 2027. High usage of scaffolds in wound healing, aesthetic surgeries, soft tissue tumor repair, abdominal wall repair, periodontology, and colorectal surgeries boost the revenue generation in this segment.
In addition, the combination of an antimicrobial agent with a tissue repair scaffold to enhance the regeneration process is expected to improve plastic and reconstructive procedures, which involve a high risk of loss of repaired tissue due to infection. The development of computational topology design and solid freeform fabrication has enabled the designing of tissue-engineering scaffolds with controlled architecture, which contributes to the growth of this segment.
In terms of revenue, the orthopedics, musculoskeletal, and spine segment held the largest revenue share of 55% in 2019 owing to the rise in the incidence of musculoskeletal and orthopedic complications.
A combination of cell therapy, drug delivery, and electrospun nanofiber scaffolds has potential in regeneration and repairing of orthopedic tissues. Topographic cues offered by these nanofibers have significantly improved the migration, adhesion, differentiation, and proliferation of cells. Thereby, the advent of new technologies, such as electrospun nanofiber scaffolds manufactured for the engineering of orthopedic tissues, further propels the segment growth.
The neurology segment is projected to expand at the fastest CAGR during the forecast period due to continuous R&D in regenerative solutions for neurological disorders. The researchers from the University of California San Diego School of Medicine and Institute of Engineering in Medicine developed a spinal cord with the help of 3D printed scaffolds as reported in January 2019. The spinal cord was loaded with neural stem cells and promotes the growth of stem cells during spinal cord injuries.
Biotechnology and pharmaceutical organizations captured the largest revenue share of 47% in 2019 due to a wide application of scaffold technology in drug discovery protocols, especially in drug screening and target validation of therapeutics.
The hospitals and diagnostic centers segment is estimated to be the fastest-growing end-use segment during the forecast period. A rise in the number of grafting procedures, coupled with road accidents and related injury cases, consequently increases the demand for biological scaffolds in hospitals. Several hospitals offer scaffold-based treatment for cardiovascular and dental surgeries, which subsequently supplements the revenue generated by this segment.
North America dominated the market with a revenue share of 41% in 2019. This can be attributed to an increase in regenerative medicine and stem cell research, a developed healthcare framework, and a rise in investments to expand the applications of these technologies.
Asia Pacific is expected to register the fastest CAGR in the forecast period owing to the presence of government agencies that focus on regenerative medicine and stem cell research.
Key Players
Merck KGaA
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
3D Biotek LLC
Molecular Matrix, Inc.
REPROCELL, Inc.
Xanofi
Tecan Trading AG
Matricel GmbH
Pelobiotech
Corning Incorporated
Akron Biotech
4titude
3D Biomatrix
Nanofiber Solutions
NuVasive, Inc.
Avacta Life Sciences Limited
Medtronic
Allergan
Vericel Corporation
Market Segmentation
Scaffold Technology Type Outlook
Hydrogels
Wound Healing
3D Bioprinting
Immunomodulation
Polymeric Scaffolds
Micropatterned Surface Microplates
Nanofiber Based Scaffolds
Scaffold Technology Application Outlook
Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
Drug Discovery
Others
Scaffold Technology Disease Type Outlook
Orthopedics, Musculoskeletal, & Spine
Cancer
Skin & Integumentary
Dental
Cardiology & Vascular
Neurology
Urology
GI & Gynecology
Others
Scaffold Technology End-use Outlook
Biotechnology and Pharmaceutical Industries
Research Laboratories and Institutes
Hospitals and Diagnostic Centers
Others
Scaffold Technology Regional Outlook
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
Japan
Latin America
Brazil
Middle East Africa (MEA)
South Africa
The Scaffold Technology market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Scaffold Technology market for the base year 2019 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Scaffold Technology market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Scaffold Technology market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Scaffold Technology market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Scaffold Technology capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Scaffold Technology by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Scaffold Technology market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Scaffold Technology market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Scaffold Technology market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Scaffold Technology industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Scaffold Technology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Scaffold Technology market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Scaffold Technology market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Scaffold Technology market. These factors have benefited the growth of the global market for Scaffold Technology. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Scaffold Technology. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Scaffold Technology are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Scaffold Technology Market, By Scaffold Technology
7.1. Scaffold Technology Market, By Scaffold Technology Type, 2020-2030
7.1.1. Hydrogels
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Polymeric Scaffolds
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Micropatterned Surface Microplates
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Nanofiber Based Scaffolds
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Scaffold Technology Market, By Application
8.1. Scaffold Technology Market, By Application, 2020-2030
8.1.1. Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Drug Discovery
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Scaffold Technology Market, By Disease Type
9.1. Scaffold Technology Market, By Disease Type, 2020-2030
9.1.1. Orthopedics, Musculoskeletal, & Spine
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Skin & Integumentary
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Dental
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Cardiology & Vascular
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. Neurology
9.1.6.1. Market Revenue and Forecast (2016-2030)
9.1.7. Urology
9.1.7.1. Market Revenue and Forecast (2016-2030)
9.1.8. GI & Gynecology
9.1.8.1. Market Revenue and Forecast (2016-2030)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Scaffold Technology Market, By End-use Type
10.1. Scaffold Technology Market, By End-use Type, 2020-2030
10.1.1. Biotechnology and Pharmaceutical Industries
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Research Laboratories and Institutes
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Hospitals and Diagnostic Centers
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Scaffold Technology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.1.2. Market Revenue and Forecast, By Application (2016-2030)
11.1.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.1.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.2.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.2.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.3.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.3.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.4.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.4.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.5.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Scaffold Technology (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Disease Type Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
Chapter 12. Company Profiles
12.1. Merck KGaA
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher Scientific, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Becton, Dickinson and Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. 3D Biotek LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Molecular Matrix, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. REPROCELL, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Xanofi
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Tecan Trading AG
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Matricel GmbH
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Pelobiotech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Corning Incorporated
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Akron Biotech
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. 4titude
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. 3D Biomatrix
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Nanofiber Solutions
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
12.16. NuVasive, Inc.
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance
12.16.4. Recent Initiatives
12.17. Avacta Life Sciences Limited.
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance
12.17.4. Recent Initiatives
12.18. Medtronic
12.18.1. Company Overview
12.18.2. Product Offerings
12.18.3. Financial Performance
12.18.4. Recent Initiatives
12.19. Allergan
12.19.1. Company Overview
12.19.2. Product Offerings
12.19.3. Financial Performance
12.19.4. Recent Initiatives
12.20. Vericel Corporation
12.20.1. Company Overview
12.20.2. Product Offerings
12.20.3. Financial Performance
12.20.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms